Biotechnology
Chelsea Therapeutics International, Ltd. announced that it will release second quarter results for the period ended June 30, 2008 before the market opens on Wednesday, August 6, 2008. Chelsea management will host a conference call and live webcast to dis
02:30 Jul 31, 2008
OrthoLogic Corp. announced today that it will release financial and operating results for the second quarter ending June 30, 2008, on Thursday, August 7, 2008.
02:10 Jul 31, 2008
The Quigley Corporation today reported net sales from continuing operations of $2.1 million, for the second quarter ended June 30, 2008, compared to $2.2 million reported for the second quarter ended June 30, 2007. For the six months ended June 30, 2008,
02:03 Jul 31, 2008
Silence Therapeutics plc , a leading European RNAi focused biotechnology company, today announced that the United States Patent and Trademark Office has allowed the Company's core RNAi patent application. The Patent Office issued a 'Notice of Allowance'
02:03 Jul 31, 2008
United Therapeutics Corporation today announced its results of operations for the quarter ended June 30, 2008.
02:03 Jul 31, 2008
TurboSonic Technologies, Inc. , a global leader in the design and supply of industrial air pollution control technologies, today announced that the company's CEO, Edward Spink is featured in an exclusive interview on WallSt.net's 3-Minute Press Show.
02:03 Jul 31, 2008
Auxilium Pharmaceuticals, Inc. , a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended June 30, 2008. For the second quarter of 2008, Auxilium reported net revenues of $30.9 million comp
02:00 Jul 31, 2008
AtheroGenics, Inc. , a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced top-line results from its ANDES Phase 3 clinical trial of AGI-1067 for the treatment of Type 2 diabetes demonstrating that both doses
02:00 Jul 31, 2008
Gentiva Health Services, Inc. , the nation's leading provider of comprehensive home health services, today reported strong second quarter results, led by double-digit increases in Medicare revenues and admissions in the Company's Home Health segment.
01:33 Jul 31, 2008
Sierra Neuropharmaceuticals, Inc., a formulator of pharmaceuticals for direct-to-the-brain treatment of neurological diseases, announced a $21.5-million venture capital Series A financing. Co-leads in the funding were HealthCare Ventures, Morgenthaler Ve
01:03 Jul 31, 2008
Following the approval by the Extraordinary General Meeting of Shareholders on 30 May 2008 to delay publication of the 2007 Annual Report, OctoPlus N.V. announces today that it will also postpone publication of its results for the first 6 months of 2008,
21:13 Jul 30, 2008
The full press release is available on http://www.solvay-investors.com/
20:44 Jul 30, 2008
Living Cell Technologies Limited today announced that the cash balance at the end of the quarter was $10,767,335 compared to $12,689,973 at the end of the quarter to March 31st 2008.
17:32 Jul 30, 2008
Biota Holdings Limited today announced that its second generation, influenza treatment, CS-8958, has successfully completed its initial Phase II clinical evaluation, showing favourable outcomes against all measured endpoints. The initial Phase III trial
16:52 Jul 30, 2008
Pyng Medical Corp. today released its unaudited third quarter fiscal 2008 results for the period ending June 30, 2008, marking the Company's seventh consecutive quarter of growth and profitability. Third quarter revenues of $1,624,967 exceeded the prior
14:44 Jul 30, 2008
45096 - 45110 of 52760 Stories
<<
<
Next 15 Biotechnology
>
>>
Search News
